Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.73 USD
−18.95 M USD
18.11 M USD
37.28 M
About Adagene Inc.
Sector
CEO
Pei Zhi Luo
Headquarters
Suzhou
Website
Founded
2011
FIGI
BBG00YZ6BYJ6
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.